Globus Medical (GMED) Tops Q3 EPS by 7c, Updates FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Globus Medical Reports Third Quarter 2018 Results
November 8, 2018 4:15 PM ESTAUDUBON, Pa., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the third quarter ended September 30, 2018.
Worldwide sales were $169.2 million, an increase of 11.5% as reportedThird quarter net income was $35.2 million, an increase of 37.6%Diluted earnings per share (EPS) was $0.35 and non-GAAP diluted EPS was $0.39Non-GAAP diluted EPS increased 29.2% compared to third quarter of 2017Non-GAAP adjusted EBITDA was 34.1% of salesThe third quarter marks the fourth consecutive quarter of... More
